PubRank

Alexandra King

Author PubWeight™ 76.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Characterization of mice lacking the gene for cholecystokinin. Am J Physiol Regul Integr Comp Physiol 2007 1.09
2 Novel activity of an anti-inflammatory cytokine: IL-10 prevents TNFalpha-induced resistance to IGF-I in myoblasts. J Neuroimmunol 2007 1.01
3 Cholecystokinin knockout mice are resistant to high-fat diet-induced obesity. Gastroenterology 2010 0.89
4 Lipids. Antibodies against PCSK9--a new era of therapy. Nat Rev Cardiol 2012 0.89
5 Public health: Health risks of physical inactivity similar to smoking. Nat Rev Cardiol 2012 0.88
6 Stem cells. Could it be TIME to abandon BMCs? Nat Rev Cardiol 2012 0.87
7 Tumor O(6)-methylguanine-DNA methyltransferase inactivation by oral lomeguatrib. Clin Cancer Res 2010 0.85
8 Children are key to CVD prevention. Nat Rev Cardiol 2010 0.79
9 Acute coronary syndromes: ACS in developing countries--insights from the ACCESS registry. Nat Rev Cardiol 2011 0.78
10 Public health: Value of echocardiographic screening for RHD in Ugandan children. Nat Rev Cardiol 2012 0.78
11 Prevention: Neuropsychiatric adverse effects signal the end of the line for rimonabant. Nat Rev Cardiol 2010 0.77
12 Erectile dysfunction and CVD. Nat Rev Cardiol 2010 0.77
13 Poor health literacy: a 'hidden' risk factor. Nat Rev Cardiol 2010 0.77
14 Elevated systolic blood pressure in middle age is associated with late-life dementia. Nat Rev Cardiol 2010 0.75
15 Valvular disease: TAVR outcomes maintained 2-years after the PARTNER trial. Nat Rev Cardiol 2012 0.75
16 Atrial fibrillation. First-line catheter ablation therapy--too much too soon? Nat Rev Cardiol 2012 0.75
17 Congenital heart conditions. Closure of PFO--more questions than answers. Nat Rev Cardiol 2013 0.75
18 Prevention: Low-dose omega-3 supplementation--no beneficial effect in patients with prior MI. Nat Rev Cardiol 2010 0.75
19 Heart failure: Registry data reveal disparities in care. Nat Rev Cardiol 2012 0.75
20 Vascular disease: Atherosclerosis unravelled--clues from ancient civilizations. Nat Rev Cardiol 2013 0.75
21 Arrhythmias. A new hybrid ablation technique for AF. Nat Rev Cardiol 2011 0.75
22 Coronary artery disease: individualize care for multivessel CAD. Nat Rev Cardiol 2013 0.75
23 Heart failure: Placing an EMPHASIS on the mineralocorticoid receptor--benefit of eplerenone in mild HF. Nat Rev Cardiol 2011 0.75
24 Risk factors: Cigarette smoking increases the risk of coronary heart disease in women more than in men. Nat Rev Cardiol 2011 0.75
25 Acute coronary syndromes: Abciximab delivered to the MI lesion reduces infarct size. Nat Rev Cardiol 2012 0.75
26 Advanced age should not be a contraindication for cardiac resynchronization therapy. Nat Rev Cardiol 2012 0.75
27 Risk factors: Eating for two? Maternal weight gain and offspring cardiovascular risk. Nat Rev Cardiol 2010 0.75
28 Device therapy: Reuse of ICDs in developing countries--'proof of concept' data published. Nat Rev Cardiol 2012 0.75
29 Acute coronary syndromes: Is early abciximab beneficial in STEMI? Nat Rev Cardiol 2012 0.75
30 Interventional cardiology: Examining the issues related to PCI without on-site surgical back-up. Nat Rev Cardiol 2012 0.75
31 Risk factors: Everything in moderation—binge drinking increases CVD risk. Nat Rev Cardiol 2011 0.75
32 Thrombosis: Choose thigh-length compression stockings for DVT prevention. Nat Rev Cardiol 2010 0.75
33 Atrial fibrillation: Is dabigatran cost-effective compared with warfarin in patients with AF? Nat Rev Cardiol 2011 0.75
34 Hypertension: Understanding patients' perceptions could improve therapy. Nat Rev Cardiol 2012 0.75
35 The dual challenge of BP control. Nat Rev Cardiol 2009 0.75
36 Arrhythmias: Widespread use of public-access AEDs improves survival after cardiac arrest. Nat Rev Cardiol 2010 0.75
37 Atrial fibrillation: new-onset AF in women--an independent risk factor or a 'canary in a coal mine'? Nat Rev Cardiol 2011 0.75
38 Arrhythmias: CPAP with ablation reduces AF in OSA. Nat Rev Cardiol 2013 0.75
39 Surgery: COPPS trial heralds new indication for colchicine. Nat Rev Cardiol 2010 0.75
40 Antiplatelet therapy: Surgery should not interrupt treatment. Nat Rev Cardiol 2011 0.75
41 Cardiomyopathies: CMR sheds new light on the clinical profile of stress cardiomyopathy. Nat Rev Cardiol 2011 0.75
42 Coronary artery disease: CABG is preferable to PCI for complex left-main or three-vessel disease. Nat Rev Cardiol 2011 0.75
43 Prevention. Cost-effectiveness of cardiovascular disease prevention and management in the developing world. Nat Rev Cardiol 2012 0.75
44 Erectile dysfunction and CVD. Nat Rev Urol 2010 0.75
45 Prevention: Fibrates reduce risk of coronary events. Nat Rev Cardiol 2010 0.75
46 Heart failure: Registry data highlight global differences in care for HF-PEF. Nat Rev Cardiol 2011 0.75
47 Prevention: the benefits of a Mediterranean diet. Nat Rev Cardiol 2013 0.75
48 Arrhythmias: apixaban triumphs over aspirin for stroke prevention in patients with atrial fibrillation. Nat Rev Cardiol 2011 0.75
49 Surgery: No benefit of cerebral perfusion over hypothermia in pulmonary endarterectomy. Nat Rev Cardiol 2011 0.75
50 Hypertension: Careful monitoring of kidney function is needed in patients with hypertension. Nat Rev Cardiol 2010 0.75
51 Eptifibatide is noninferior to abciximab: implications for clinical practice. Nat Rev Cardiol 2010 0.75
52 Risk factors: Fried foods not linked to CHD in Spain. Nat Rev Cardiol 2012 0.75
53 Cyclosporine after MI. Nat Rev Cardiol 2010 0.75
54 Digital technology in cardiac care. Nat Rev Cardiol 2010 0.75
55 Stroke: parental stroke is an independent risk factor for stroke and transient ischemic attack. Nat Rev Cardiol 2010 0.75
56 Prevention: Statins go beyond cardioprotection. Nat Rev Cardiol 2011 0.75
57 Atrial fibrillation: Could subclinical AF be a missing link in the etiology of cryptogenic stroke? Nat Rev Cardiol 2012 0.75
58 Heart failure: TITAN trial results published. Nat Rev Cardiol 2012 0.75
59 Imaging cerebral microemboli during TAVI. Nat Rev Cardiol 2012 0.75
60 Surgery: radial artery grafts not superior to saphenous vein grafts at 1 year after CABG surgery. Nat Rev Cardiol 2011 0.75
61 Thrombosis: Selective D-dimer testing improves efficiency of DVT diagnosis. Nat Rev Cardiol 2013 0.75
62 Valvular disease: the UK TAVI experience: insights from the 'real world'. Nat Rev Cardiol 2011 0.75
63 Diagnosis. Novel protocol for risk assessment of patients with chest pain. Nat Rev Cardiol 2011 0.75
64 Heart failure: poor health literacy increases mortality. Nat Rev Cardiol 2011 0.75
65 Valvular disease: PARTNER cohort A-TAVR is an option for operable severe aortic stenosis. Nat Rev Cardiol 2011 0.75
66 Heart failure. Promising data for serelaxin. Nat Rev Cardiol 2012 0.75
67 Interventional cardiology: Radial access improves PCI outcomes. Nat Rev Cardiol 2012 0.75
68 Interventional cardiology: New insights into PCI for chronic total occlusion. Nat Rev Cardiol 2012 0.75
69 Novel omega-3 agent reduces residually high triglyceride levels in patients treated with statins. Nat Rev Cardiol 2012 0.75
70 Vascular disease: aortic plaque--dual therapy for a heterogeneous disease. Nat Rev Cardiol 2013 0.75
71 Atrial fibrillation: First head-to-head comparison of catheter and surgical ablation for drug-refractory AF. Nat Rev Cardiol 2011 0.75
72 Air pollution reduces EPC levels. Nat Rev Cardiol 2010 0.75
73 Diabetes: olmesartan slows microalbuminuria. Nat Rev Cardiol 2011 0.75
74 Interventional cardiology. Radial artery access--a RIVAL to the femoral approach. Nat Rev Cardiol 2011 0.75
75 Device therapy: avoid apical lead position in CRT. Nat Rev Cardiol 2011 0.75
76 Congenital heart conditions: Clear benefits of pulse oximetry in neonates--one small step to improving postnatal cardiac care. Nat Rev Cardiol 2011 0.75
77 Risk factors: Pregnancy loss increases risk of MI. Nat Rev Cardiol 2011 0.75
78 Arrhythmias: RAAS inhibition in atrial fibrillation-one strike, but not out? Nat Rev Cardiol 2011 0.75
79 Lipids: Cardioprotective effects of HDL cholesterol called into question. Nat Rev Cardiol 2012 0.75
80 Obesity: long-term benefits of gastric bypass on cardiac structure and function. Nat Rev Cardiol 2011 0.75
81 Prevention: Small reductions in risk factors equal big savings in health-care costs. Nat Rev Cardiol 2011 0.75
82 Arrhythmias. Ablation of atrioventricular nodal re-entrant tachycardia is safe and effective in the elderly. Nat Rev Cardiol 2011 0.75
83 Arrhythmias: High-dose, prescription omega-3 fatty acids do not prevent recurrent AF. Nat Rev Cardiol 2011 0.75
84 Coronary heart disease: New hope for CETP inhibitors. Nat Rev Cardiol 2011 0.75
85 Hypertension: AT1 autoantibodies and response to therapy. Nat Rev Cardiol 2011 0.75
86 Interventional cardiology: Cormorbidity index could help select elderly patients for SES implantation. Nat Rev Cardiol 2011 0.75
87 Atrial fibrillation: RF needle improves septal puncture. Nat Rev Cardiol 2011 0.75
88 Acute coronary syndromes: Air pollution and survival after MI. Nat Rev Cardiol 2013 0.75
89 Prevention. Statin therapy--if at first you don't succeed... Nat Rev Cardiol 2013 0.75
90 Interventional cardiology: Antithrombotic therapy for PCI--getting the balance right. Nat Rev Cardiol 2013 0.75
91 Prevention. Low adoption of healthy lifestyles. Nat Rev Cardiol 2013 0.75
92 Device therapy: Clinical sequelae of cardiac device-related endocarditis. Nat Rev Cardiol 2012 0.75
93 Thrombosis: An effective therapy for leg SVT. Nat Rev Cardiol 2010 0.75
94 Atrial fibrillation: HAS-BLED--a new risk score to predict bleeding in patients with AF. Nat Rev Cardiol 2011 0.75
95 Cardiac resuscitation: Optimum CPR strategies clarified. Nat Rev Cardiol 2011 0.75
96 Atrial fibrillation: Is short-term antiarrhythmic therapy an option? Nat Rev Cardiol 2012 0.75
97 Atrial fibrillation: Strict rate control unnecessary in AF? Nat Rev Cardiol 2011 0.75
98 Vascular disease. Corticosteroid therapy improves outcomes for Japanese children with Kawasaki disease. Nat Rev Cardiol 2012 0.75
99 Antiplatelet therapy: Making the SWAP from clopidrogrel to prasugrel. Nat Rev Cardiol 2010 0.75
100 Arrhythmias: home AEDs-a question of rhythm? Nat Rev Cardiol 2011 0.75
101 Notes from the Field: Counterfeit Percocet-Related Overdose Cluster - Georgia, June 2017. MMWR Morb Mortal Wkly Rep 2017 0.75
102 "Every One of Us Is a Strand in That Basket": Weaving Together Stories of Indigenous Wellness and Resilience From the Perspective of Those With Lived and Living Experience With HIV/Hepatitis C Virus. J Assoc Nurses AIDS Care 1 0.75
103 Prevention: could flu vaccine join the secondary prevention armamentarium for ACS? Nat Rev Cardiol 2011 0.75